September 28, 2011 — Cardiac monitoring company Cardiac Network Inc., along with its joint venture partner Pacific Coast Innovations (PCI) LLC announced it is completing the work on its new Central Monitoring System (CMS). The new system, as described below, was built by the companies relating to the design of a new, technologically advanced monitoring device, related data storage and monitoring infrastructure.

September 28, 2011 — The 24th annual International Symposium on Endovascular Therapy (ISET) will take place Jan. 15-19, 2012, at the Fontainebleau Miami Beach. More than 1,500 members of the global endovascular community will be in attendance; this includes physicians, researchers, scientists, biomedical engineers, nurses, technologists and other industry professionals. The fields of interventional radiology, interventional cardiology and vascular surgery will be represented, among others.

September 28, 2011 — A clinical trial by Resverlogix Corp. is evaluating the early effects of a new drug compound in atherosclerotic plaque regression. The study is focused on patients with coronary artery disease who have a low level of high-density lipoprotein cholesterol (HDL-C).

September 28, 2011 –Ziehm Imaging said its holding company Aton GmbH acquired 100 percent of the United States-based mini C-arm specialist OrthoScan Inc.

September 27, 2011 – Calgary Scientific Inc. has received clearance from the U.S. Food and Drug Administration (FDA) to market medical imaging application, ResolutionMD Mobile, as a mobile diagnostic application in the United States. With this secure, highly scalable, server-based software solution, physicians anywhere can rapidly access, view and interact with patient images and reports stored within any healthcare facility, and render a clinical diagnosis using their mobile devices. Prior non-diagnostic versions of this product are currently distributed and licensed under original equipment manufacturer (OEM) agreements with global leaders in medical imaging and information technology. In addition to the recent FDA clearance, ResolutionMD Mobile has also been licensed by Health Canada and bears the CE mark for distribution in Europe.

Subscribe Now